Search research articles
Contact Us
Filters
Showing results (221-230 of 226) with videos related to
Page
of 23
Sort By:
You have reached the last page of results.
This site can display upto 226 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study
F Donskov, H von der Maase, R Henriksson, et al.
Journal of Neuro-Oncology
|
December 31, 2010
Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
S Sjöström, C Wibom, U Andersson, et al.
Oncology
|
May 1, 1993
Role of ondansetron plus dexamethasone in fractionated chemotherapy
U Räth, B K Upadhyaya, E Arechavala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E Le Rhun, M Weller, D Brandsma, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
R H Dahlrot, J Dowsett, S Fosmark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Page
of 23
Search research articles
Search
Showing results (221-230 of 226) with videos related to
Sort By:
Page
of 23
You have reached the last page of results.
This site can display upto 226 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 9, 2002
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study
F Donskov, H von der Maase, R Henriksson, et al.
Journal of Neuro-Oncology
|
December 31, 2010
Genetic variations in VEGF and VEGFR2 and glioblastoma outcome
S Sjöström, C Wibom, U Andersson, et al.
Oncology
|
May 1, 1993
Role of ondansetron plus dexamethasone in fractionated chemotherapy
U Räth, B K Upadhyaya, E Arechavala, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 9, 2017
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours
E Le Rhun, M Weller, D Brandsma, et al.
Neuropathology and Applied Neurobiology
|
June 3, 2017
Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis
R H Dahlrot, J Dowsett, S Fosmark, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2001
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse
M Brada, K Hoang-Xuan, R Rampling, et al.
Page
of 23